Exelixis, Inc. (EXEL)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

27

0

7

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
25-Mar-24 7:31 PM View:	21-Mar-24 Planned Private Option Sale ($461.11K)	Garber Alan M Director		Exelixis, Inc. - EXEL	14% 31.42K to 35.7K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 6:58 PM View:	23-Feb-24 Grant 0	Morrissey Michael M President and CEO Director		Exelixis, Inc. - EXEL	11% 2.25M to 2.49M	0	0	--	--	Show Txns Hide Txns

27-Feb-24 6:58 PM View:	23-Feb-24 Grant 0	Senner Christopher J. EVP and CFO		Exelixis, Inc. - EXEL	12% 672.59K to 754.71K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 6:58 PM View:	23-Feb-24 Sale ($1.01M)	Haley Patrick J. EVP, Commercial		Exelixis, Inc. - EXEL	4% 402.72K to 419.05K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 6:58 PM View:	23-Feb-24 Grant 0	Hessekiel Jeffrey EVP, General Counsel & Sec		Exelixis, Inc. - EXEL	11% 592.7K to 656.05K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 6:58 PM View:	23-Feb-24 Grant 0	Aftab Dana CSO/EVP Disc & Trans Research		Exelixis, Inc. - EXEL	11% 495.5K to 548.22K	0	0	--	--	Show Txns Hide Txns

22-Feb-24 5:08 PM View:	21-Feb-24 Purchase $3.93M	Johnson David Edward Director		Exelixis, Inc. - EXEL	20% 928.91K to 1.12M	0	0	--	--	Show Txns Hide Txns

27-Feb-24 6:59 PM View:	23-Feb-24 Grant 0	Peterson Amy C. EVP Prod Dev & Med Aff & CMO		Exelixis, Inc. - EXEL	34% 240.0K to 322.12K	0	0	--	--	Show Txns Hide Txns